These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8386761

  • 1. Higher-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown.
    Meghji S, Henderson B, Wilson M.
    J Periodontal Res; 1993 Mar; 28(2):115-21. PubMed ID: 8386761
    [Abstract] [Full Text] [Related]

  • 2. Serum antibody response to surface-associated material from periodontopathogenic bacteria.
    Meghji S, Henderson B, Kirby A, Newman HN, Wilson M.
    FEMS Immunol Med Microbiol; 1995 Jan; 10(2):101-8. PubMed ID: 7719276
    [Abstract] [Full Text] [Related]

  • 3. Humoral immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease.
    Kinane DF, Mooney J, Ebersole JL.
    Periodontol 2000; 1999 Jun; 20():289-340. PubMed ID: 10522229
    [No Abstract] [Full Text] [Related]

  • 4. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease.
    Genco RJ, Zambon JJ, Murray PA.
    J Periodontol; 1985 Nov; 56(11 Suppl):41-50. PubMed ID: 3908639
    [Abstract] [Full Text] [Related]

  • 5. Humoral antibody responses in periodontal disease.
    Zafiropoulos GG, Flores-de-Jacoby L, Hungerer KD, Nisengard RJ.
    J Periodontol; 1992 Feb; 63(2):80-6. PubMed ID: 1313106
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an antiproliferative surface-associated protein from Actinobacillus actinomycetemcomitans which can be neutralized by sera from a proportion of patients with localized juvenile periodontitis.
    White PA, Wilson M, Nair SP, Kirby AC, Reddi K, Henderson B.
    Infect Immun; 1995 Jul; 63(7):2612-8. PubMed ID: 7790076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis.
    Lamster IB, Kaluszhner-Shapira I, Herrera-Abreu M, Sinha R, Grbic JT.
    J Clin Periodontol; 1998 Jun; 25(6):510-6. PubMed ID: 9667485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.
    Guentsch A, Puklo M, Preshaw PM, Glockmann E, Pfister W, Potempa J, Eick S.
    J Periodontal Res; 2009 Jun; 44(3):368-77. PubMed ID: 19210340
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis.
    Choi JI, Ha MH, Kim JH, Kim SJ.
    Infect Immun; 1996 Oct; 64(10):4226-30. PubMed ID: 8926092
    [Abstract] [Full Text] [Related]

  • 12. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
    Rams TE, Listgarten MA, Slots J.
    J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
    [Abstract] [Full Text] [Related]

  • 13. Attachment loss and serum antibody levels against autologous and reference strains of Actinobacillus actinomycetemcomitans in untreated localized juvenile periodontitis patients.
    Tinoco EM, Lyngstadaas SP, Preus HR, Gjermo P.
    J Clin Periodontol; 1997 Dec; 24(12):937-44. PubMed ID: 9442433
    [Abstract] [Full Text] [Related]

  • 14. Simple and rapid detection of serum antibody to periodontopathic bacteria by dot blotting.
    Kawashima Y, Ishikawa I.
    J Periodontal Res; 2002 Jun; 37(3):223-9. PubMed ID: 12113558
    [Abstract] [Full Text] [Related]

  • 15. The effects of periodontal therapy on serum antibody levels to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis (part II).
    Unsal BT, Ozcan G, Baloş K, Gün H.
    J Marmara Univ Dent Fac; 1996 Sep; 2(2-3):474-8. PubMed ID: 9569801
    [Abstract] [Full Text] [Related]

  • 16. Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.
    Horibe M, Watanabe H, Ishikawa I.
    J Clin Periodontol; 1995 Jul; 22(7):510-5. PubMed ID: 7560233
    [Abstract] [Full Text] [Related]

  • 17. IgG sera levels against a subset of periodontopathogens and severity of disease in aggressive periodontitis patients: a cross-sectional study of selected pocket sites.
    Saraiva L, Rebeis ES, Martins Ede S, Sekiguchi RT, Ando-Suguimoto ES, Mafra CE, Holzhausen M, Romito GA, Mayer MP.
    J Clin Periodontol; 2014 Oct; 41(10):943-51. PubMed ID: 25070874
    [Abstract] [Full Text] [Related]

  • 18. Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients.
    Chen HA, Johnson BD, Sims TJ, Darveau RP, Moncla BJ, Whitney CW, Engel D, Page RC.
    J Periodontol; 1991 Dec; 62(12):781-91. PubMed ID: 1662718
    [Abstract] [Full Text] [Related]

  • 19. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia.
    Choi YH, McKeown RE, Mayer-Davis EJ, Liese AD, Song KB, Merchant AT.
    J Periodontol; 2014 Sep; 85(9):1172-81. PubMed ID: 24410292
    [Abstract] [Full Text] [Related]

  • 20. Recognition of antigenic epitopes in lipopolysaccharide and protein from Actinobacillus actinomycetemcomitans by serum antibodies in untreated rapidly progressive periodontitis patients.
    Ou JG, Bainbridge B, Gu K, Sims TJ, Whitney CW, Darveau RP, Chen HA, Houston LS, Page RC.
    Oral Microbiol Immunol; 1997 Feb; 12(1):11-9. PubMed ID: 9151639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.